Suppr超能文献

[妊娠期重度高血压的治疗]

[Treatment of severe hypertension in pregnancy].

作者信息

Oney T, Weitzel H

机构信息

Frauenklinik und Poliklinik im Klinikum Steglitz, Freien Universität Berlin.

出版信息

Z Geburtshilfe Perinatol. 1991 Jan-Feb;195(1):1-9.

PMID:2053378
Abstract

Treatment of severe hypertension in pregnancy, particularly in preeclampsia and eclampsia, is a great challenge to the obstetrician and requires prompt and expert management. Application of antihypertensive agents is limited during pregnancy because of possible side effects, particularly impairment of the fetal state. The following survey present a detailed discussion on the substances suitable for treating hypertensive emergencies in pregnancy and their side effects. Despite restricted therapeutic possibilities, safe and successful treatment of severe hypertension during pregnancy can best be performed with dihydralazine and diazoxide, which achieve their effect by reducing the peripheral vascular resistance. If the blood pressure cannot be adequately reduced with these substances, treatment can be continued with sodium nitroprusside. A critical discussion is presented in this connection on drugs such as clonidine and reserpine, which reduce pressure largely by central mechanisms and should no longer be applied in pregnant patients because of serious disadvantages. Consideration is also given to the special clinical problems associated with pheochromocytomas, and a concluding discussion deals with the perspectives of antihypertensive therapy in pregnancy.

摘要

妊娠期重度高血压的治疗,尤其是子痫前期和子痫的治疗,对产科医生来说是一项巨大挑战,需要迅速且专业的处理。由于可能存在副作用,尤其是对胎儿状态的损害,妊娠期使用抗高血压药物受到限制。以下综述详细讨论了适用于治疗妊娠期高血压急症的药物及其副作用。尽管治疗选择有限,但妊娠期重度高血压的安全有效治疗最好使用双肼屈嗪和二氮嗪,它们通过降低外周血管阻力发挥作用。如果使用这些药物血压仍无法充分降低,可继续使用硝普钠治疗。本文还对可乐定和利血平等药物进行了批判性讨论,这些药物主要通过中枢机制降低血压,由于存在严重缺点,不应再用于孕妇。文中还考虑了与嗜铬细胞瘤相关的特殊临床问题,最后讨论了妊娠期抗高血压治疗的前景。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验